Aberrant expression of E-cadherin in lung tissues of patients with probable lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 5149-5153

  Yuan, Yu Lin ^a,b   Wang, Yu Ming ^c   Liu, Hua ^c   Qin, Gui Fang ^b   Tang, Ai Guo ^a   Duan, Yong ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Aberrant expression; E cadherin; Lung cancer diagnosis; Lung tissue

Indexed keywords

EID: 84874016937     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.5149     Document Type: Article

References (29)

1. Ahmedin Jemal DVM, Freddie Bray, Melissa M, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90.
2. Brambilla E, Travis WD, Colby TV, et al (2001). The new World Health Organization classification of lung tumours. Eur Respir J, 18, 1059-68.
3. Bukholm IK, Nesland JM, Karesen R, et al (1998). E-cadherin and alpha-, beta- and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol, 185, 262-6.
4. Comijn J, Berx G, Vermassen P, et al (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell, 7, 1267-78.
5. Demirci U, Ozdemir N, Benekli M, et al (2012). Lymphoproliferative disorders in multiple primary cancers. Asian Pac J Cancer Prev, 13, 383-6.
6. Feng QH, Hawes SE, Stern JE, et al (2008). DNA Methylation in Tumor and Matched Normal Tissues from Non-Small Cell Lung Cancer Patients. Cancer Epidemiol Biomarkers Prev, 17, 645-54.
7. Guo HM, Zhang XQ, Xu CH, et al (2011). Expression of E-cadherin and alpa-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Asian Pac J Cancer Prev, 12, 3433-8.
8. Hennig G, Behrens J, Truss M, et al (1995). Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene, 11, 475-84.
9. Herbst RS, Yano S, Kuniyasu H, et al (2000). Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res, 6, 690-7.
10. Hirata T, Fukuse T, Naiki H, et al (2001). Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer. Clin Lung Cancer, 3, 134-40.
11. Hirohashi S (1998). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol, 153, 333-9.
12. Kimman M, Norman R, Jan S, et al (2012). The burden of cancer in member countries of the association of southeast asian nations (ASEAN). Asian Pac J Cancer Prev, 13, 411-20.
13. Li WT, Liu CL, Tang Y, et al (2011). Overexpression of snail accelerates adriamycin induction of multidrug resistance in breast cancer cells. Asian Pac J Cancer Prev, 12, 2575-80.
14. Liu D, Huang D, Kameyama K, et al (2001). E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg, 71, 949-55.
15. Mir MR, Shabir N, Wani KA, et al (2012). Association between p16, Hmlh1 and E-cadherin promoter hypermethylation and intake of local hot salted tea and sun-dried foods in Kashmiris with gastric tumors. Asian Pac J Cancer Prev, 13, 181-6.
16. Mitselou A, Batistatou A, Nakanishi Y, et al (2010). Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites. Histol Histopathol, 25, 1257-67.
17. Oda H, Takeichi M (2011). Evolution: structural and functional diversity of cadherin at the adherens junction. J Cell Biol, 193, 1137-46.
18. Paras J, Mushal N, Robert G, et al (2008). Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol, 14, 1044-52.
19. Perez-Moreno MA, Locascio A, Rodrigo I, et al (2001). A new role for E12/E47 in the repression of E-cadherin expression and epithelial- mesenchymal transitions. J Biol Chem, 276, 27424-31.
20. Ramezani F, Salami S, Omrani MD, et al (2012). CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. Asian Pac J Cancer Prev, 13, 451-7.
21. Schmidt CR, Gi YJ, Patel TA, et al (2005). E-cadherin is regulated by the transcriptional repressor SLUG during Ras-mediated transformation of intestinal epithelial cells. Surgery, 138, 306-12.
22. Shibanuma H, Hirano T, Tsuji K, et al (1998). Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer. Lung Cancer, 22, 85-95.
23. Shuang Y, Jun D, Zhaoqi W, et al (2007). BMP-6 promotes E-cadherin expression through repressing δEF1 in breast cancer cells. BMC Cancer, 7, 211
24. Stefanou D, Goussia AC, Arkoumani E, et al (2003) Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer. Anticancer Res, 23, 4715-20.
25. Sun HH, Cui H, Jin YM, et al (2011). Genetic analysis of liver metastatic cell lines with different metastatic potential. Asian Pac J Cancer Prev, 12, 3257-63.
26. Tamura G, Yin J, Wang S, et al (2000). E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst, 92, 569-73.
27. Umbas R, Schalken JA, Aalders TW, et al (1992). Expression of the cellular adhesion molecue E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res, 52, 5104-9.
28. van Roy F, Berx G (2008). The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci, 65, 3756-88.
29. Yu T, Hou FG, Liu MM, et al (2012). Norcantharidin anti-angiogenesis activity possibly through an endothelial cell pathway in human colorectal cancer. Asian Pac J Cancer Prev, 13, 499-503.